Correction: Removal of pharmaceutical residues by Ferrate(VI) (PLoS ONE (2013) 8, 2,(e55729) DOI: 10.1371/journal.pone.0055729);Removal of Pharmaceutical Residues by Ferrate(VI)

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Jiang, JiaQian ^a   Zhou, Zhengwei ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM DIATRIZOATE; ATENOLOL; BEZAFIBRATE; CARBAMAZEPINE; CHEMICAL COMPOUND; CIPROFLOXACIN; DRUG; ERYTHROMYCIN; FERRATE VI; IBUPROFEN; IFOSFAMIDE; IOPAMIDOL; LIDOCAINE; N ACETYLSULFAMETHOXAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; PH; PHYSICAL CHEMISTRY; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT;

EID: 84873575906     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/annotation/c4b7f63f-efae-463e-88c4-ee6c47982ba0     Document Type: Erratum

References (45)

1. Wang L, Ying GG, Zhao JL, Yang XB, Chen F, et al. (2010) Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China, Science of the Total Environment. 408: 3139-3147.
2. Comeau F, Surette C, Brun GL, Losier R, (2008) The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada, Science of the Total Environment. 396: 132-146.
3. Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H, (2006) Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment, Water Research. 40: 3297-3303.
4. Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, et al. (2006) Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada, Science of the Total Environment. 367: 544-558.
5. Ternes TA, (1998) Occurrence of drugs in German sewage treatment plants and rivers, Water Research. 32: 3245-3260.
6. Lee HB, Peart TE, Svoboda ML, (2007) Determination of ofloxacin, norfloxacin, and ciprofloxacin in sewage by selective solid-phase extraction, liquid chromatography with fluorescence detection, and liquid chromatography-tandem mass spectrometry, Journal of Chromatography A. 1139: 45-52.
7. Ferrari B, Paxeus N, Giudice RL, Pollio A, Grric J, (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicology and Environmental Safety 55 (3): 359-370.
8. Jjemba PK, (2006) Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicology and Environmental Safety 63 (1): 113-130.
9. Grung M, Kallqvist T, Sakshaug S, Skurtveit S, Thomas KV, (2008) Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicology and Environmental Safety 71 (2): 328-340.
10. Daughton CG, Ternes TA, (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environmental Health Perspectives 107 (S6): 907-938.
11. Ternes TA, (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Research 32 (11): 3245-3260.
12. Paxeus N, (2004) Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Science and Technology 50 (5): 253-260.
13. Castiglioni S, Bagnati R, Fanelli R, Pomati F, Calamari D, et al. (2006) Removal of pharmaceuticals in sewage treatment plants in Italy. Environmental Science and Technology 40 (1): 357-363.
14. Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H, (2006) Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Research 40 (17): 3297-3303.
15. Santos JL, Aparicio I, Alonso E, (2007) Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environment International 33 (4): 596-601.
16. Okuda T, Kobayashi Y, Nagao R, Yamashita N, Tanaka H, et al. (2008) Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan. Water Science and Technology 57 (1): 65-71.
17. Comerton AM, Andrews RC, Bagley DM, Hao CY, (2008) The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties. Journal of Membrane Science 313 (1-2): 323-335.
18. Snyder SA, Adham S, Redding AM, Cannon FS, DeCarolis J, et al. (2007) Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202: 156-181.
19. Westerhoff P, Yoon Y, Snyder S, Wert E, (2005) Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during Simulated drinking water treatment processes. Environmental Science & Technology 39: 6649-6663.
20. Jiang JQ, (2007) Research progress in the use of ferrate(VI) for the environmental remediation, Journal of Hazardous Materials. 146: 617-623.
21. Jiang JQ, (2001) Development of coagulation theory and pre-polymerised coagulants for water treatment. Separation and Purification Methods 30: 127-141.
22. Jiang JQ, Lloyd B, Grigore L, (2001) Preparation and evaluation of potassium ferrate as an oxidant and coagulant for potable water treatment. Environmental Engineering Science 18: 323-328.
23. Jiang JQ, Lloyd B, (2002) Progress in the development and use of ferrate (vi) salt as an oxidant and coagulant for water and wastewater treatment. Water Research 36: 1397-1408.
24. Filip J, Yngard RA, Siskova K, Marusak Z, Ettler V, (2011) Mechanisms and efficiency of the simultaneous removal of metals and cyanides by using ferrate(VI): Crucial roles of nanocrystalline iron achtungtrenung(III) oxyhydroxides and metal carbonates. Chem. Eur. J. 17: 10097-11005.
25. Sharma VK, (2002) Potassium ferrate(VI): an environmentally friendly oxidant. Adv. Environ. Res. 6(2): 143-156.
26. Jiang JQ, Panagoulopoulos A, Bauer M, Pearce P, (2006) The application of potassium ferrate for sewage treatment. Journal of Environmental Management 79(2): 215-220.
27. Jiang JQ, Wang S, Panagoulopoulos A, (2007) The role of potassium ferrate(VI) in the inactivation of Escherichia coli and in the reduction of COD for water remediation. Desalination 210: 266-273.
28. Jiang JQ, Stanford C, Alsheyab M, (2009) The online generation and application of ferrate(VI) for sewage treatment-A pilot scale trial. Separation and Purification Technology 68(2): 227-231.
29. Stanford C, Jiang JQ, Alsheyab M, (2010) Electrochemical production of ferrate (iron VI): application to the wastewater treatment on a laboratory scale and comparison with iron (III) coagulant. Water, Air, and Soil Pollution 209: 483-488.
30. Jiang JQ, Stanford C, Mollazeinal A, (2012) The application of ferrate for sewage treatment: pilot- to full-scale trials, Global NEST Journal 14. (1): 93-99.
31. Sharma VK, Sohn M, Anquandah GAK, Nesnas N, (2012) Kinetics of the oxidation of sucralose and related carbohydrates by ferrate(VI). Chemosphere 87: 644-648.
32. Sharma VK, (2010) Oxidation of nitrogen-containing pollutants by novel ferrate(VI) technology: A review. J. Environ. Sci. Health, A: Toxic/Hazardous Sub. Environ. Eng. 45(6): 645-667.
33. Jiang JQ, Yin Q, Zhou JL, Pearce P, (2005) Occurrence and treatment trials of endocrine disrupting chemicals (EDCs) in wastewaters. Chemosphere 61(4): 544-550.
34. Seitz W, Jiang JQ, Schulz W, Weber WH, Maier D, et al. (2008) Formation of oxidation by-products of the iodinated X-ray contrast medium iomeprol during ozonation. Chemosphere 70(7): 1238-1246.
35. Yang B, Ying G-G, Zhao J-L, Liu S, Zhou L-J, et al. (2012) Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents, Water Research. 46: 2194-2204.
36. Anquandah GAK, Sharma V, Knight AD, Batchu SR, Gardinali PR, (2011) Oxidation of trimethoprim by ferrate(VI): kinetics, products, and antibacterial activity. Environ. Sci. Technol. 45: 10575-10581.
37. Sharma V, Luther GW, Millero FJ, (2011) Mechanisms of oxidation of organosulfur compounds by ferrate(VI). Chemosphere 82: 1083-1089.
38. Sharma VK, Li XZ, Graham N, Doong RA, (2008) Ferrate(VI) oxidation of endocrine disruptors and antimicrobials in water. Water Supply: Res. Technol.- AQUA 57(6): 419-426.
39. Lee Y, Zimmermann SG, Kieu AT, von Gunten U, (2009) Ferrate (Fe(VI)) Application for Municipal Wastewater Treatment: A Novel Process for Simultaneous Micropollutant Oxidation and Phosphate Removal, Environ. Sci. Technol. 43: 3831-3838.
40. Carr JD, Kelter PB, Tabatabai A, Splichal D, Erickson J, et al. (1985) Properties of ferrate (VI) in aqueous solution: an alternate oxidant in wastewater treatment, In Jolley, R. L. Et Al., 1285-1298.
41. Zhou Z, Jiang JQ, (2012) Detection of ibuprofen and ciprofloxacin by solid phase extraction and UV/Vis spectroscopy, J. Applied Spectroscopy 79. (3): 477-481.
42. Jiang JQ, Zhou Z, Pahl O, (2012) Preliminary study of ciprofloxacin (cip) removal by potassium ferrate(VI). Separation and Purification Technology 88: 95-98.
43. Sharma,VK, Mishra SK, (2006) Ferrate(VI) oxidation of ibuprofen: A kinetic study. Environmental Chemistry Letters 3: 182-185.
44. Hu L, Martin HM, Arce-Bulted O, Sugihara MN, Keating KA, et al. (2009) Oxidation of carbamazepine by Mn(VII) and Fe(VI): reaction kinetics and mechanism. Environ. Sci. Technol. 43: 509-515.
45. Sharma VK, Burnett CR, Millero FJ, (2001) Dissociation constants of the monoprotic ferrate(VI) ion in NaCl media. Phys. Chem. Chem. Phys. 3: 2059-2062.